SAN DIEGO (MedPage Today) -- Lowering homocysteine levels with folic acid supplementation yielded no cardiovascular benefit for stable renal transplant recipients, a randomized trial showed.
ASN: No CVD Benefit for Folic Acid in Kidney Transplant (CME/CE)Courtesy MedPage Today Surgery Tue, 11/03/2009 - 11:24
SAN DIEGO (MedPage Today) -- Lowering homocysteine levels with folic acid supplementation yielded no cardiovascular benefit for stable renal transplant recipients, a randomized trial showed. Popular products Tags:
More related itemsStepped Dosing Lessens Neuropsychiatric Effects of...
ATS: Antifibrotic Slows IPF Progress (CME/CE)
Living-Donor Kidney Transplant Nomograms Predict...
Pedifix Wart Stick Solid-stick Wart Remover Net...
Ride 'Em Cowgirl! Sex Position Secrets For Better...
|
Popular by tags WeekMonth |
Post new comment